Anthera Announces FDA Orphan Drug Designation for Blisibimod for the Treatment of IgA Nephropathy
Go back to Anthera Announces FDA Orphan Drug Designation for Blisibimod for the Treatment of IgA Nephropathy| ANTHERA PHARMA (AMEX: ANTH) | Delayed: 0.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.00 | 52 Week High | $6.08 | |||
| Open | $0.00 | 52 Week Low | $1.72 | |||
| Day High | $0.00 | P/E | 0.00 | |||
| Day Low | $0.00 | EPS | $-1.47 | |||
| Volume | 1,404 | |||||
